- Home
- ALLR vs CTHR Comparison
ALLR vs CTHR Comparison
Compare ALLR & CTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- CTHR
- Stock Information
- Founded
- ALLR 2004
- CTHR 1995
- Country
- ALLR United States
- CTHR United States
- Employees
- ALLR N/A
- CTHR N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- CTHR Consumer Specialties
- Sector
- ALLR Health Care
- CTHR Consumer Discretionary
- Exchange
- ALLR Nasdaq
- CTHR Nasdaq
- Market Cap
- ALLR 4.5M
- CTHR 4.1M
- IPO Year
- ALLR N/A
- CTHR 1997
- Fundamental
- Price
- ALLR $1.05
- CTHR $1.42
- Analyst Decision
- ALLR
- CTHR
- Analyst Count
- ALLR 0
- CTHR 0
- Target Price
- ALLR N/A
- CTHR N/A
- AVG Volume (30 Days)
- ALLR 218.5K
- CTHR 326.6K
- Earning Date
- ALLR 11-14-2024
- CTHR 02-11-2025
- Dividend Yield
- ALLR N/A
- CTHR N/A
- EPS Growth
- ALLR N/A
- CTHR N/A
- EPS
- ALLR N/A
- CTHR N/A
- Revenue
- ALLR N/A
- CTHR $23,684,860.00
- Revenue This Year
- ALLR N/A
- CTHR $31.82
- Revenue Next Year
- ALLR N/A
- CTHR N/A
- P/E Ratio
- ALLR N/A
- CTHR N/A
- Revenue Growth
- ALLR N/A
- CTHR N/A
- 52 Week Low
- ALLR $0.90
- CTHR $1.16
- 52 Week High
- ALLR $378.00
- CTHR $4.90
- Technical
- Relative Strength Index (RSI)
- ALLR 39.84
- CTHR 51.60
- Support Level
- ALLR $0.90
- CTHR $1.16
- Resistance Level
- ALLR $1.14
- CTHR $1.87
- Average True Range (ATR)
- ALLR 0.08
- CTHR 0.12
- MACD
- ALLR 0.02
- CTHR 0.04
- Stochastic Oscillator
- ALLR 66.67
- CTHR 36.62
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About CTHR Charles & Colvard Ltd
Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market. The company sells jewels through two operating segments namely Online Channels segment and Traditional segment. It generates maximum revenue from the Online Channels segment. Online Channels segment which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets.